- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540596660
3540596666
- Dimensions
-
24 cm
- Extent
-
304 S.
- Language
-
Englisch
- Notes
-
graph. Darst.
Literaturangaben. - Teilw. auch mehrbd. begrenztes Werk
- Keyword
-
Krebs
Chemotherapie
- Event
-
Veröffentlichung
- (where)
-
Paris, Berlin, Heidelberg, New York, Barcelona, Hong Kong, London, Milan, Santa Clara, Singapore, Tokyo
- (who)
-
Springer
- (when)
-
1999
- Contributor
-
Hortobagyi, Gabriel N.
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
- 11.06.2025, 2:25 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Aufsatzsammlung
Associated
- Hortobagyi, Gabriel N.
- Springer
Time of origin
- 1999
Other Objects (12)
Progress in anti-cancer chemotherapy, Vol. 4
Progress in chemotherapy, Vol. 3.. Anticancer section
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anti-cancer effects of statins on castration- and chemotherapy- resistant prostate cancer cells
Targeting CDK9 for anti-cancer therapeutics
Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study
Molecular aspects of anti-cancer drug action
Iridium compounds as prospective anti-cancer agents
Anti-cancer potential of South Asian plants
Network insights on oxaliplatin anti-cancer mechanisms
Anti-cancer properties of quercetin in osteosarcoma
A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis
Progress in anti-cancer chemotherapy, Vol. 4
Progress in chemotherapy, Vol. 3.. Anticancer section
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anti-cancer effects of statins on castration- and chemotherapy- resistant prostate cancer cells
Targeting CDK9 for anti-cancer therapeutics
Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study
Molecular aspects of anti-cancer drug action
Iridium compounds as prospective anti-cancer agents
Anti-cancer potential of South Asian plants
Network insights on oxaliplatin anti-cancer mechanisms
Anti-cancer properties of quercetin in osteosarcoma
A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis
Progress in anti-cancer chemotherapy, Vol. 4
Progress in chemotherapy, Vol. 3.. Anticancer section
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anti-cancer effects of statins on castration- and chemotherapy- resistant prostate cancer cells
Targeting CDK9 for anti-cancer therapeutics
Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study
Molecular aspects of anti-cancer drug action
Iridium compounds as prospective anti-cancer agents
Anti-cancer potential of South Asian plants
Network insights on oxaliplatin anti-cancer mechanisms
Anti-cancer properties of quercetin in osteosarcoma